agenttrading

Does Stock Rover Have Backtesting? Screening vs Testing

July 22, 2026 · Agenttrading · Last updated July 2026

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
01 THESIS · AS A TESTABLE RULE

02 EVIDENCE · FUNDAMENTALS

03 BACKTEST · GROWTH OF $10,000
Strategy Buy & hold

04 RISK · IN PLAIN ENGLISH

05 VERDICT · HISTORICAL, NOT PREDICTIVE

Past performance does not guarantee future results. Educational analysis only, not financial advice.

Stock Rover does not have backtesting in the trading sense. What it has is historical screening, available on the Premium Plus, Ultimate, and Ultimate Pro plans, which lets you query what fundamental metrics looked like in earlier years. That is a genuinely useful research feature, and it answers a different question from a backtest. Historical screening tells you which companies met your criteria in the past. A backtest tells you what would have happened if you had traded a rule on that signal, including the drawdown you would have sat through.

The distinction gets blurred constantly in reviews, so it is worth pinning down before you pay for a tier you do not need.

What Stock Rover actually offers instead of backtesting

Stock Rover is one of the strongest fundamental research desks built for retail investors, and none of what follows is a knock on it. It just has a lane.

Stock Rover featureWhat it doesThe limit
ScreenerFilters stocks, ETFs, and mutual funds on more than 700 fundamental metricsShows what qualifies now, with no entry or exit logic
Historical screeningRuns criteria against past years, for example ten straight years of dividend growthQueries past fundamentals; it does not simulate holding or selling
Portfolio analyticsCompares your holdings against benchmarks, with correlation and allocation viewsAnalyzes what you own, not a rule you are considering
Charts and ratingsPrice charts, fair value estimates, and scoring across peersA view of the present, not a rule tested across decades

Notice that no row simulates a trade. Every one of them describes a state, either today's or a past year's, and none of them steps forward through time applying a rule and recording what it earned or lost.

What is historical screening in Stock Rover?

Historical screening lets you build criteria against past data rather than only against current numbers. You can ask for companies that raised the dividend every year for the last ten, or whose return on invested capital is more than five percent higher than it was six years ago. The lookback window depends on the plan: five years on Premium, ten on Premium Plus, and twenty on the Ultimate tiers. Only Premium Plus and above include the feature at all.

For a fundamentals-driven investor, that is real value. It surfaces consistency, which a single-year snapshot hides. What it will not tell you is whether buying those companies at the moment they qualified, and selling when they stopped qualifying, would have made money after costs.

Screening and backtesting answer different questions

The cleanest way to see the gap is to put the two questions side by side.

Screening (including historical)Backtesting
Question answeredWhich securities met these criteria?What would trading this rule have returned?
Handles timeA snapshot, or a snapshot of a past yearSteps forward day by day, holding and exiting
Includes costsNoYes, if the tool is honest
Reports drawdownNoYes, the worst peak-to-trough loss
Compares to buy-and-holdNoYes, the only benchmark that matters
Typical failure modeSurvivorship: today's list only shows the survivorsOverfitting: tuning until the past looks perfect

The survivorship point deserves emphasis because it bites screener users hardest. A screen run today over historical fundamentals is generally looking at companies that still exist. The ones that were delisted, acquired, or went to zero are not in the list, and they were exactly the ones that would have hurt. A backtest built on adjusted price history for the securities as they traded then is the honest counterweight.

How much does Stock Rover cost?

As of July 2026, Stock Rover runs four paid tiers: Premium at roughly $34 per month or $348 per year, Premium Plus at roughly $70 per month or $588 per year, Ultimate at roughly $99 per month or $948 per year, and Ultimate Pro at roughly $199 per month or $1,788 per year. There is a 14-day trial of any plan. The V12 release in May 2026 added the Ultimate tiers along with 20 years of historical fundamentals and an options chain. Because historical screening starts at Premium Plus, the entry price for the feature people mistake for backtesting is the second tier, not the first. Prices change, so confirm on their pricing page before you subscribe.

Can you backtest a screener?

Not inside Stock Rover, and the general idea is harder than it sounds anywhere. Backtesting a screen properly means rebuilding the universe as it existed on each rebalance date, including companies that later disappeared, then applying entry rules, exit rules, position sizing, and costs. Platforms that do this well tend to be institutional and expensive. What most investors actually need is narrower and much more answerable: take the rule you would trade on one or a few tickers and test that rule honestly across decades.

Is Stock Rover worth it?

If your process is fundamentals-first and long-horizon, yes, it is one of the better values in retail research: the screener depth, the portfolio analytics, and the historical fundamentals hold up against tools costing far more. If you bought it expecting to test trading rules, you bought the wrong tool, and no tier upgrade fixes that. The wider question of what a screen can and cannot deliver on its own is taken apart in do stock screeners work. Most people who want both end up pairing a screener with a separate testing bench, which is cheaper than climbing tiers looking for a feature that is not there.

How to test the rule you would actually trade

Once you have candidates, the workflow that turns a screen into a decision looks like this.

  1. Write the rule as one sentence. "Buy AAPL when the 50-day crosses above the 200-day, sell on the reverse cross." If you cannot state it in a sentence, it is not testable yet, it is a mood.
  2. Test it on 20+ years of adjusted daily data, with costs. Split- and dividend-adjusted prices and a realistic cost per trade. A rule that only works at zero cost is not a rule, it is a rounding error. Survivorship bias belongs on the same list of common backtesting mistakes that quietly inflate a result.
  3. Compare it to simply holding. Most timing rules lose to buy-and-hold once costs are in. Knowing that before you commit is the entire point of testing.
  4. Read the drawdown, not the return. The worst peak-to-trough loss and how long recovery took tell you whether you could have actually stayed in the trade. Returns you abandon at the bottom are not returns.
  5. Check the trade count. A great result built on nine trades is an anecdote. More trades over more market regimes means more signal.

That loop is what Agenttrading is built for, and it is deliberately not a screener, a broker, or a signal service. You type the thesis in plain English, it restates the rule so you can see exactly what will run, backtests it on 20+ years of split- and dividend-adjusted daily data with a 0.1% cost per trade assumed by default, explains drawdown and volatility in words, and stamps a one-line verdict: HELD UP, MIXED, or UNDERPERFORMED, including when your idea loses to buy-and-hold. Use Stock Rover to find the names, then vet the rule.

The full side-by-side is on the Stock Rover alternative page, the mechanics live on backtesting software, and fundamental analysis tools covers what gets read per ticker. If you are also comparing screeners, the Finviz alternative page covers that side, and how to backtest a trading strategy walks the whole method start to finish.

Put it on the bench

Ideas are cheap. Verdicts take a bench.

Agenttrading restates your idea as a testable rule, backtests it on 20+ years of adjusted daily data, and explains the risks in plain English. Honest verdicts, even when the idea loses.

Past performance does not guarantee future results. For educational and informational purposes only. Not financial advice. Consult a licensed advisor.